Adverse event ‐ multiple pregnancy · subfertile women with polycystic ovary syndrome
Myo‐inositol showed no clear difference in adverse event ‐ multiple pregnancy compared with placebo, no/standard treatment (low certainty).
1 finding from 1 review
Clinical pregnancy · subfertile women with polycystic ovary syndrome
It is very uncertain whether myo‐inositol changes clinical pregnancy compared with placebo, no/standard treatment (very low certainty).
1 finding from 1 review
Adverse event ‐ multiple pregnancy · subfertile women with polycystic ovary syndrome
It is very uncertain whether myo‐inositol changes adverse event ‐ multiple pregnancy compared with antioxidant (melatonin) (very low certainty).
1 finding from 1 review
Clinical pregnancy · subfertile women with polycystic ovary syndrome
It is very uncertain whether myo‐inositol changes clinical pregnancy compared with antioxidant (melatonin) (very low certainty).
1 finding from 1 review
Clinical pregnancy rate · Women with polycystic ovary syndrome, oligo amenorrhoea and subfertility
Metformin probably leads to higher clinical pregnancy rate per woman compared with placebo or no treatment (moderate certainty).
1 finding from 1 review
Ongoing pregnancy · subfertile women
It is very uncertain whether natural cycle FET changes ongoing pregnancy rate per woman compared with modified natural cycle FET (HCG trigger) (very low certainty).
1 finding from 1 review
Multiple pregnancy rate · subfertile women
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Ongoing pregnancy · subfertile women
Modified natural cycle FET (HCG trigger) showed no clear difference in ongoing pregnancy rate per woman compared with HT FET (low certainty).
1 finding from 1 review
Multiple pregnancy rate · subfertile women
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Ongoing pregnancy · women with primary or secondary subfertility
It is very uncertain whether HT FET changes ongoing pregnancy rate per woman compared with HT + GnRHa FET (very low certainty).
1 finding from 1 review
Multiple pregnancy rate · women with primary or secondary subfertility
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Ongoing pregnancy · subfertile women
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Multiple pregnancy rate · subfertile women
It is very uncertain whether HMG FET changes multiple pregnancy rate per woman compared with clomiphene + HMG FET (very low certainty).
1 finding from 1 review
Ongoing pregnancy · subfertile women
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Multiple pregnancy rate · subfertile women
It is very uncertain whether natural cycle FET changes multiple pregnancy rate per woman compared with HT FET (very low certainty).
1 finding from 1 review
Clinical pregnancy rate · Women undergoing IVF/ICSI cycles
Glucocorticoid supplementation showed no clear difference in clinical pregnancy rate per woman/couple compared with placebo (low certainty).
1 finding from 1 review
Multiple pregnancy rate · Women undergoing IVF/ICSI cycles
It is very uncertain whether glucocorticoid supplementation changes multiple pregnancy rate per woman/couple compared with placebo (very low certainty).
1 finding from 1 review
Ongoing pregnancy · Women undergoing ovarian stimulation with gonadotrophins in IVF and ICSI procedures
Recombinant luteinizing hormone (rLH) combined with recombinant… probably leads to higher ongoing pregnancy rate compared with rFSH alone (moderate certainty).
1 finding from 1 review
Clinical pregnancy rate · for controlled ovarian stimulation
Clomiphene citrate or letrozole with or without gonadotropins (with… showed no clear difference in clinical pregnancy rate per woman compared with gonadotropins (with GnRH agonists or midcycle antagonist) (moderate certainty).
1 finding from 1 review
Clinical pregnancy rate · Women undergoing controlled ovarian stimulation in IVF and ICSI cycles (poor responders)
Clomiphene citrate or letrozole with or without gonadotropins (with… showed no clear difference in clinical pregnancy rate per woman compared with gonadotropins (with GnRH agonist or midcycle antagonist) (low certainty).
1 finding from 1 review